Key result
Serum ascorbic acid and alpha-tocopherol levels were not significantly associated with diabetic retinopathy after excluding supplement users (OR 0.7, 95% CI 0.3-1.4 and OR 1.6, 95% CI 0.9-2.9).
Why the study?
Do higher serum levels of ascorbic acid and alpha-tocopherol prevent diabetic retinopathy in patients with type 2 diabetes?
Cross-Sectional (n=998)
Yes
Do higher serum levels of ascorbic acid and alpha-tocopherol prevent diabetic retinopathy in patients with type 2 diabetes?
Odds Ratio: 1.3 (95% CI 0.8–2.3)
p-value: p=0.60
Serum levels of ascorbic acid and alpha-tocopherol are not significantly associated with a reduced prevalence of diabetic retinopathy in patients with type 2 diabetes.
The protective relation of ascorbic acid and alpha-tocopherol to the development of diabetic retinopathy has not been thoroughly evaluated in epidemiologic studies. The association of prevalent diabetic retinopathy with serum ascorbic acid and alpha-tocopherol was studied among participants with type 2 diabetes (>or=40 years) (n = 998) in the Third National Health and Nutrition Examination Survey (1988-1994); 20% of the sample (n = 199) had prevalent retinopathy. The overall odds ratio for retinopathy among participants in quartile 4 compared with quartile 1 for serum ascorbic acid was 1.3 (95% confidence interval: 0.8, 2.3), with a p for trend = 0.60 after adjustment for the confounders of smoking, race, waist/hip ratio, hypertension, and duration of diabetes. The overall odds ratio for retinopathy among participants in quartile 4 compared with quartile 1 for serum alpha-tocopherol was 2.7 (95% confidence interval: 1.6, 4.6), with a p for trend = 0.14 after adjustment for confounders. After removal of supplement users of vitamin C (n = 307) or vitamin E (n = 298), the odds ratio changed direction or was attenuated: adjusted odds ratios for retinopathy among participants in quartile 4 compared with quartile 1 for serum ascorbic acid and alpha-tocopherol = 0.7 (95% confidence interval: 0.3, 1.4) and 1.6 (95% confidence interval: 0.9, 2.9), respectively. In summary, no significant associations were observed between serum levels of major dietary antioxidants and retinopathy. Recent use of supplements for treatment of complications of diabetes may explain the direct associations.
No takes yet. Share an insight, caveat, or question.
Amy E. Millen (2003) conducted a cross-sectional in Type 2 diabetes (n=998). Serum ascorbic acid and alpha-tocopherol vs. Quartile 1 (lowest serum levels) was evaluated on Prevalent diabetic retinopathy (OR 1.3, 95% CI 0.8, 2.3, p=0.60). Serum ascorbic acid and alpha-tocopherol levels were not significantly associated with diabetic retinopathy after excluding supplement users (OR 0.7, 95% CI 0.3-1.4 and OR 1.6, 95% CI 0.9-2.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: